Encompass Health CorporationEHCNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +12.69% | +10.59% | +12.03% | +9.36% | +9.94% |
| Gross Profit Growth | +14.46% | +15.57% | +15.43% | +24.07% | -39.96% |
| EBITDA Growth | +20.15% | +23.14% | +18.38% | +12.12% | +19.81% |
| Operating Income Growth | -47.77% | +28.67% | +20.18% | +16.50% | +22.00% |
| Net Income Growth | +38.01% | +34.67% | +24.54% | +16.91% | +20.84% |
| EPS Growth | +36.36% | +33.93% | +24.78% | +16.67% | +21.67% |
| EPS Diluted Growth | +37.21% | +34.55% | +24.11% | +16.98% | +22.03% |
| Weighted Average Shares Growth | +0.50% | +0.70% | +0.70% | +0.60% | +0.20% |
| Weighted Average Shares Diluted Growth | +0.79% | -0.10% | +0.20% | +0.20% | -0.29% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +38.71% | +20.85% | +24.29% | +1.12% | +24.10% |
| Free Cash Flow Growth | +0.00% | +26.26% | +87.27% | -30.42% | +45.69% |
| Receivables Growth | -2.09% | +0.66% | +3.87% | +5.97% | +3.41% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +7.08% | +6.58% | +6.21% | +6.31% | +8.49% |
| Book Value per Share Growth | +24.84% | +23.09% | +23.10% | +20.40% | +17.72% |
| Debt Growth | -7.47% | -7.42% | -8.81% | -4.93% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +3.13% | +4.67% | +14.53% | -17.98% | -1.16% |